Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

NCT02871518 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Cisplatin combine with IMRT
DRUG: Cisplatin combine with IMRT

Sponsor

Sun Yat-sen University